Furthermore, while MUT BCs and LPs had a similar number of unique enhancers, 85% of MUT BC enhancers were unique compared to 39% of MUT LP enhancers, supporting the notion that BRCA1 mutation affects BCs more than LPs. The gene discussed is BRCA1; the disease is breast cancer.